Pfizer Inc. (PFE)

52.31 -0.12 (-0.23%) At close: 04:03PM EDT

Pfizer Inc.

235 East 42nd Street
New York, NY 10017
United States
212 733 2323
https://www.pfizer.com

Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full Time Employees: 79,000

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Albert Bourla D.V.M., DVM, Ph.D.	Chairman & CEO	11.07M	2.61M	1962
Mr. Frank A. D'Amelio	CFO & Exec. VP	5.14M	3.82M	1958
Dr. Mikael Dolsten M.D., Ph.D.	Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical	5.36M	N/A	1958
Mr. Douglas M. Lankler	Exec. VP & Gen. Counsel	3.78M	1.85M	1966
Mr. John D. Young	Advisor	4.25M	3.54M	1965
Ms. Angela Hwang	Group Pres of Biopharmaceuticals Group	4.79M	391.86k	1966
Mr. David M. Denton	Chief Financial Officer & Exec. VP	N/A	N/A	1965
Ms. Jennifer B. Damico	Sr. VP, Controller & Principal Accounting Officer	N/A	N/A	1968
Ms. Lidia L. Fonseca	Exec. VP and Chief Digital & Technology Officer	N/A	N/A	1969
Mr. Christopher J. Stevo CFA	Sr. VP & Chief Investor Relations Officer	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.’s ISS Governance QualityScore as of June 1, 2022 is 3. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.